BACKGROUND: ENABLE (Educate, Nurture, Advise Before Life Ends) II was one of the first randomized controlled trials (RCTs) examining the effects of a concurrent oncology palliative care intervention on quality of life, mood, and symptom control for advanced cancer patients and their caregivers. However, little is known about how participants experience early palliative care and the benefits and burdens of participating in a palliative care clinical trial. AIM: To gain a deeper understanding of participants' perspectives of the intervention and palliative care trial participation. DESIGN: A qualitative descriptive study using thematic analysis to determine benefits and burdens of a new palliative care intervention and trial participation. SETTING/PARTICIPANTS: Of the 72 participants who were alive when the study commenced, 53 agreed to complete an in-depth, semi-structured interview regarding the ENABLE II intervention and clinical trial participation. RESULTS: Participants' perceptions of intervention benefits were represented by four themes: enhanced problem-solving skills, better coping, feeling empowered, and feeling supported or reassured. Three themes related to trial participation: helping future patients and contributing to science, gaining insight through completion of questionnaires, and trial/intervention aspects to improve. CONCLUSIONS: The benefits of the intervention and the positive aspects of trial participation outweighed trial "burdens". This study raises additional important questions relevant to future trial design and intervention development: when should a palliative care intervention be initiated and what aspects of self-care and healthy living should be offered in addition to palliative content for advanced cancer patients when they are feeling well?
BACKGROUND: ENABLE (Educate, Nurture, Advise Before Life Ends) II was one of the first randomized controlled trials (RCTs) examining the effects of a concurrent oncology palliative care intervention on quality of life, mood, and symptom control for advanced cancer patients and their caregivers. However, little is known about how participants experience early palliative care and the benefits and burdens of participating in a palliative care clinical trial. AIM: To gain a deeper understanding of participants' perspectives of the intervention and palliative care trial participation. DESIGN: A qualitative descriptive study using thematic analysis to determine benefits and burdens of a new palliative care intervention and trial participation. SETTING/PARTICIPANTS: Of the 72 participants who were alive when the study commenced, 53 agreed to complete an in-depth, semi-structured interview regarding the ENABLE II intervention and clinical trial participation. RESULTS: Participants' perceptions of intervention benefits were represented by four themes: enhanced problem-solving skills, better coping, feeling empowered, and feeling supported or reassured. Three themes related to trial participation: helping future patients and contributing to science, gaining insight through completion of questionnaires, and trial/intervention aspects to improve. CONCLUSIONS: The benefits of the intervention and the positive aspects of trial participation outweighed trial "burdens". This study raises additional important questions relevant to future trial design and intervention development: when should a palliative care intervention be initiated and what aspects of self-care and healthy living should be offered in addition to palliative content for advanced cancer patients when they are feeling well?
Authors: Anne Lambert-Kerzner; Edward P Havranek; Mary E Plomondon; Karen Albright; Ashley Moore; Kelsey Gryniewicz; David Magid; P Michael Ho Journal: Circ Cardiovasc Qual Outcomes Date: 2010-10-05
Authors: Carole A Robinson; Barbara Pesut; Joan L Bottorff; Andrea Mowry; Sandra Broughton; Gillian Fyles Journal: J Palliat Med Date: 2009-02-13 Impact factor: 2.947
Authors: Pam McGrath; Alex Moore; Meg McNaught; Gail Palmer; Anne Greene; Dawn Atkinson Journal: Support Care Cancer Date: 2005-04-16 Impact factor: 3.603
Authors: Marie Bakitas; Marguerite Stevens; Tim Ahles; Marie Kirn; Karen Skalla; Nancy Kane; E Robert Greenberg Journal: J Palliat Med Date: 2004-04 Impact factor: 2.947
Authors: Kathleen D Lyons; Jay G Hull; Peter A Kaufman; Zhongze Li; Janette L Seville; Tim A Ahles; Alice B Kornblith; Mark T Hegel Journal: J Psychosoc Oncol Date: 2015-02-10
Authors: Joseph A Greer; Allison J Applebaum; Juliet C Jacobsen; Jennifer S Temel; Vicki A Jackson Journal: J Clin Oncol Date: 2020-02-05 Impact factor: 44.544
Authors: Veerawat Phongtankuel; Lauren Meador; Ronald D Adelman; Jordan Roberts; Charles R Henderson; Sonal S Mehta; Tessa Del Carmen; M C Reid Journal: Am J Hosp Palliat Care Date: 2016-11-10 Impact factor: 2.500
Authors: Kathleen E Bickel; Cari Levy; Edward R MacPhee; Keri Brenner; Jennifer S Temel; Joanna J Arch; Joseph A Greer Journal: J Pain Symptom Manage Date: 2020-05-21 Impact factor: 3.612
Authors: Wiebke Jensen; Laura Bialy; Gesche Ketels; Freerk T Baumann; Carsten Bokemeyer; Karin Oechsle Journal: Support Care Cancer Date: 2013-12-07 Impact factor: 3.603
Authors: J Nicholas Dionne-Odom; Andres Azuero; Kathleen D Lyons; Jay G Hull; Tor Tosteson; Zhigang Li; Zhongze Li; Jennifer Frost; Konstantin H Dragnev; Imatullah Akyar; Mark T Hegel; Marie A Bakitas Journal: J Clin Oncol Date: 2015-03-23 Impact factor: 44.544
Authors: Marie A Bakitas; Tor D Tosteson; Zhigang Li; Kathleen D Lyons; Jay G Hull; Zhongze Li; J Nicholas Dionne-Odom; Jennifer Frost; Konstantin H Dragnev; Mark T Hegel; Andres Azuero; Tim A Ahles Journal: J Clin Oncol Date: 2015-03-23 Impact factor: 44.544
Authors: Jessica J Fulton; Thomas W LeBlanc; Toni M Cutson; Kathryn N Porter Starr; Arif Kamal; Katherine Ramos; Caroline E Freiermuth; Jennifer R McDuffie; Andrzej Kosinski; Soheir Adam; Avishek Nagi; John W Williams Journal: Palliat Med Date: 2018-11-29 Impact factor: 4.762